Compare ThredUp Inc (TDUP) vs Zoetis Inc (ZTS) Price & Performance

ThredUp (TDUP) trades at $3.17, up 0.96% on the day, but remains under pressure after a significant Q2 2026 earnings miss and lowered full-year revenue guidance. The stock's technical picture is bearish, while fundamentals show improving revenue growth but persistent losses. Recent news highlights an ongoing securities investigation related to the guidance revision, contributing to negative sentiment.

The outlook is cautious. While analyst consensus is technically 'Buy' (57% of ratings), recent operational setbacks and the stock's sharp decline post-earnings suggest significant near-term risk. The primary opportunity lies in the company's high gross margins and active buyer growth, but profitability remains elusive and investor confidence is fragile.

Zoetis (ZTS) trades at $75.83, up 0.64% on the day, but near its 52-week low after recent pressure. The stock shows bearish technical signals with support at $71 and resistance at $76. Fundamentally, the company maintains strong profitability with a 27.69% net margin and 64.91% ROE, though Q2 2026 revenue missed estimates and full-year guidance was cut due to softer pet healthcare demand. Recent news includes an FDA emergency use authorization for a new treatment and a class action lawsuit deadline.

The outlook is mixed: valuation appears reasonable with a P/E of 12, and analyst consensus targets $94.90, implying upside. However, near-term headwinds from competitive pressures and legal risks warrant caution. Long-term investors may find value if execution improves, but volatility could persist amid demand challenges.